Simvastatin affects the PPARĪ± signaling pathway and causes oxidative stress and embryonic development interference in Mugilogobius abei.
Sign Up to like & getrecommendations! Published in 2021 at "Aquatic toxicology"
DOI: 10.1016/j.aquatox.2021.105951
Abstract: Simvastatin (SV) is a common hypolipidemic drug in clinical medicine that can reduce endogenous cholesterol biosynthesis by inhibiting hydroxyl-methyl-glutaryl coenzyme A reductase. SV took a large market share in the lipid-lowering drugs and it is… read more here.
Keywords: simvastatin; mugilogobius abei; embryonic development; abei ... See more keywords